EGFR and lung carcinoma: Furthermore, the inhibitory effects of phenformin on the proliferation of H292 ER cells were significantly decreased by HK2 overexpression, indicating that enhanced glycolysis reduces the anticancer effects of phenformin in lung cancer cells with acquired EGFR-TKI resistance (Figure 5(d)).